XML 63 R44.htm IDEA: XBRL DOCUMENT v3.24.1.u1
SHARE-BASED COMPENSATION (Tables)
12 Months Ended
Dec. 31, 2023
SHARE-BASED COMPENSATION [Abstract]  
Employee Share Option Activity
The following table summarizes the Company’s share option activity under the Plan:

 
Number of
options
   
Weighted
average
exercise
price
   
Weighted
average
remaining
contractual
term
   
Aggregate
intrinsic value
 
         
$
   
Years
   
$
 
                             
Outstanding, January 1, 2021
   
47,465,720
     
14.76
               
Granted
   
4,162,121
     
269.09
               
Exercised
   
(5,405,228
)
   
14.44
               
Forfeited
   
                       
Outstanding, December 31, 2021
   
46,222,613
     
37.70
     
6.89
     
8,822,987
 
Vested and expected to vest at December 31, 2021
   
46,222,613
     
37.70
                 
Exercisable as of December 31, 2021
   
30,707,210
     
14.13
     
6.32
     
6,435,641
 
Outstanding, January 1, 2022
   
46,222,613
     
37.70
                 
Granted
   
30,000,000
     
120.00
                 
Cancelled or forfeited
    (4,012,516 )     279.17                  
Exercised
   
(3,676,911
)
   
13.82
                 
Outstanding, December 31, 2022
   
68,533,186
     
60.87
     
7.30
     
1,433,420
 
Vested and expected to vest at December 31, 2022
   
68,533,186
     
60.87
                 
Exercisable as of December 31, 2022
   
36,880,548
     
22.99
     
5.97
     
1,274,793
 
Outstanding, January 1, 2023
   
68,533,186
                         
Granted
   
1,925,000
     
60.00
                 
Cancelled or forfeited
    (9,292,295 )     104.02                  
Exercised
   
(1,336,980
)
    7.19                  
Outstanding, December 31, 2023
   
59,828,911
     
55.34
     
6.18
     
944,611
 
Vested and expected to vest at December 31, 2023
   
59,828,911
     
55.34
                 
Exercisable as of December 31, 2023
   
42,877,386
     
35.29
     
5.51
     
887,174
 
Assumptions Used for Estimated Fair Value of Options
The Company calculated the estimated fair value of the options on the respective grant dates using the Black-Scholes Option Pricing Model with the following assumptions:

 
Granted in 2021
 
Granted in 2022
 
Granted in 2023
             
Risk-free interest rates
 
0.74% – 1.07%
 
2.79% – 2.84%
 
3.60% – 4.10%
Expected term
 
5.6 – 7.5 years
 
5.1 – 7.5 years
 
6.5 – 7 years
Expected volatility
 
32.1% – 33.0%
 
48.7% – 55.9%
 
60.2% – 62.0%
Expected dividend yield
 
 
 
RSAs/RSUs Activity
The following table summarizes the Company’s RSAs/RSUs activity under the Plan:

 
Number of
RSAs/RSUs
   
Weighted
average grant
date fair value
   
Weighted
average
remaining
contractual life
   
Aggregate
intrinsic value
 
         
$
   
Years
   
$
 
                         
Unvested, January 1, 2021
   
9,341,928
     
46.36
     
8.64
     
1,859,511
 
Granted
   
3,551,491
     
258.97
                 
Vested
   
(4,127,006
)
   
40.59
                 
Forfeited
   
(637,193
)
   
102.92
                 
Unvested, December 31, 2021 and January 1, 2022
   
8,129,220
     
137.76
     
8.47
     
1,818,588
 
Granted
   
7,320,443
     
99.25
                 
Vested
   
(3,864,257
)
   
110.34
                 
Forfeited
   
(1,933,175
)
   
133.12
                 
Unvested, December 31, 2022 and January 1, 2023
   
9,652,231
     
120.48
     
8.81
     
502,206
 
Granted
   
7,119,505
     
63.46
                 
Vested
   
(4,130,583
)
   
109.11
                 
Forfeited
   
(1,786,921
)
   
116.01
                 
Unvested, December 31, 2023
   
10,854,232
     
90.02
     
8.86
     
439,596
 
Total Compensation Expense of Share Options, RSAs, RSUs and SARs Granted to Employees
Total compensation expense relating to share options, RSAs, RSUs and SARs granted to employees after deducting forfeitures recognized for the years ended December 31, 2021, 2022 and 2023 is as follows:

 
Year ended December 31,
 
   
2021
   
2022
   
2023
 
             
                         
Share options:
                       
Cost of revenue
   
390
     
     
 
Sales and marketing expenses
   
5
     
     
 
General and administrative expenses
   
207,204
     
313,917
     
253,408
 
Research and development expenses
   
33
     
254
     
44
 
     
207,632
     
314,171
     
253,452
 
                         
Cash received for the exercise in the respective years
   
77,639
     
50,211
     
10,643
 
                         
RSAs/ RSUs:
                       
Cost of revenue
   
8,318
     
11,104
     
12,727
 
Sales and marketing expenses
   
23,350
     
36,812
     
35,988
 
General and administrative expenses
   
67,421
     
67,388
     
99,048
 
Research and development expenses
   
148,592
     
283,747
     
282,381
 
     
247,681
     
399,051
     
430,144
 
                         
SARs:
                       
Cost of revenue
   
3,389
     
(1,928
)
   
383
 
Sales and marketing expenses
   
6,850
     
(1,762
)
   
710
 
General and administrative expenses
   
3,658
     
(2,993
)
   
200
 
Research and development expenses
   
1,114
     
(643
)
   
141
 
     
15,011
     
(7,326
)
   
1,434